COMPANY PROFILE

Nuance Pharma

Explore full profile

We Are A Specialty Care

Jing'an District, ChinaFounded 2014Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Nuance Pharma

Nuance Pharma is a biopharmaceutical company focused on developing and commercializing innovative treatments for respiratory and allergy-related conditions. Operating primarily in the Asian market, Nuance Pharma serves patients and healthcare providers by bringing advanced therapies to regions with significant unmet medical needs. The company partners with global pharmaceutical firms to license and develop first-in-class and best-in-class products, ensuring they meet local regulatory requirements and clinical standards. Nuance Pharma generates revenue through the commercialization of these licensed products, including nasal sprays and vaccines, and through strategic partnerships and collaborations. The business model is centered on leveraging its extensive R&D experience and regulatory expertise to expedite the availability of novel therapies in its target markets. Key clients include hospitals, clinics, and healthcare providers in China, Hong Kong, and Macau.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2014
Headquarters: Jing'an District, China
Employees: 13
Open positions: None listed
Dealroom signal: 23.7/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Drug Development, Respiratory, Allergy, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES E✓Equity / VC	Jul 2025	$41M	$614M	Konruns Pharmaceutical · Shunxi Private Equity Fund Management · Chang Development	↗
SERIES DEquity / VC	Dec 2020	$0	—	Undisclosed	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Nuance Pharma website traffic

Latest recorded traffic for Nuance Pharma is 1.1K monthly website visits, up 37.5% over the last three months. Nuance Pharma's team grew 0% over the past year.

Latest monthly visits1.1K 3-month web change+37.5% 1-year team growth0%

Monthly website visitsDec 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
TTTetra Pharm TechnologiesTetra Pharm is a research focused biopharmaceutical company delivering cannabinoid based therapies	Hillerød, Denmark	Operational	38	$12M	$40M
MMModel MedicinesLeveraging the historical compendium of drug development data and unbiased AI to create Phase II/III ready drug candidates faster	San Diego, United States	Operational
CTCeleris TherapeuticsPredicting biomolecular interactions and designing drugs for incurable diseases	Graz, Austria	Operational
BPBeckley PsytechClinical-stage biotechnology developing rapid-acting psychedelic medicines	Beckley and Stowood, United Kingdom	Operational
PBPersephone BiosciencesSynthetic biology company developing a platform to industrialize and scale the microbiome	San Diego, United States	Operational
OBOchre BioDevelops RNA therapies for chronic liver diseases, a leading cause of death globally	Oxford, United Kingdom	Operational
XIXilisDeveloping next generation technologies for precision medicine and drug discovery	Durham, United States	Operational
CHCheMasteryRobotic automation platform for chemical research and manufacturing	London, United Kingdom	Operational